Sioux Technologies co-led SamanTree’s series A round, which will support marketing of the EPFL spinout’s subcellular resolution microscopy scanner for surgical cancer interventions.

TU Dresden-founded drug discovery platform operator Dynabind has advanced research from the lab of Yixin Zhang in the university’s B Cube Center for Molecular Bioengineering.

Existing backer Samsung Ventures contributed to a round that boosted the health maintenance platform developer's overall funding to more than $86m.

Psyomics has added an undisclosed seed sum to capital previously raised from Parkwalk Advisors-managed vehicles Opportunities Fund and University of Cambridge Enterprise Fund.

The funding, provided by investors including Qbic, will allow VUB and VIB spinout Confo Therapeutics to accelerate its drug discovery efforts and move towards clinical trials.

Promethera Biosciences has increased its series D round to $44.4m with a $33.1m Mitsui and Medipal-backed extension, adding to Itochu’s initial investment earlier this year.

A consortium involving public-private partnership HTGF has supplied funding to University of Bremen spinout Mirdetect to help a molecular diagnostics blood draw for testicular cancer.

University of Twente-founded cartilage repair injection developer Hy2Care is currently targeting orthopaedic knee applications in veterinary and human healthcare settings.

Center Laboratories Group and Formosa Laboratories are in line for exits as cancer drug developer Tot Biopharm aims to go public.

Regenerative implant producer OssDsign, based on research at Karolinska University Hospital and Uppsala University, hopes to list on the Nasdaq First North and raise $15.8m.